ArticleCell reports. Medicine2026

A poly(I:C)/QS-21-based in situ vaccine synergizes with anti-PD-1 therapy to overcome tumor immunoresistance.

Wenbo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.